Vittorio Fusco
Alessandria, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Prevalence of medication-related osteonecrosis of the jaw (MRONJ) in breast cancer patients receiving low-dose bone modifying agents for cancer treatment-induced bone loss (CTIBL): need for further data.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 09, 2026
Possible Contribution of Oral Microbiota in the Osteonecrosis of the Jaw Induced by Zoledronate or Denosumab: A Preliminary Study.
Journal: Biomedicines
Published: March 04, 2026
Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022-2024).
Journal: Pharmacological reports : PR
Published: December 29, 2025
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study.
Journal: Journal of bone oncology
Published: November 23, 2025
Corrigendum to "Evaluation of a context-aware chatbot using retrieval-augmented generation for answering clinical questions on medication-related osteonecrosis of the jaw" [J. Craniomaxillofac. Surg. 53 (2025) 355-360].
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
Published: November 18, 2025
Palbociclib and risk of medication related osteonecrosis of the jaw (MRONJ): another word of cautiousness.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology
Published: October 02, 2025
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.
Journal: Tumori
Published: September 15, 2025
Medication-related osteonecrosis of the jaw primary prevention: multidomain long-term intervention versus pre-bisphosphonate treatment standalone dental intervention. A retrospective multi-center comparative cohort study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 26, 2025
Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory study.
Journal: Frontiers in oral health
Published: August 11, 2025
Trastuzumab and other new drugs potentially involved in medication-related osteonecrosis of the jaws (MRONJ): need of rules?
Journal: Oral surgery, oral medicine, oral pathology and oral radiology
Published: March 15, 2025
Oropharyngeal adverse drug reactions: knowledge, attitudes, and practice (KAP) among Italian healthcare professionals and students.
Journal: Frontiers in public health
Published: February 07, 2025
Correction: Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?"
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: September 18, 2024
Last Updated: 09/26/2026